Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson's disease

J Enzyme Inhib Med Chem. 2016;31(3):464-9. doi: 10.3109/14756366.2015.1037750. Epub 2015 Jul 15.

Abstract

(E)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides have been reported as novel multifunctional neuroprotective agents in previous studies, which as phenolic compounds display antioxidative and antineuroinflammatory properties. To further enhance the neuroprotective effects and study structure-activity relationship of the derivatives, we synthesized their acetylated derivatives, (E)-3,4-diacetoxystyryl sulfones and sulfoxides, and examined their neuroprotective effects in vitro models of Parkinson's disease. The results indicate that (E)-3,4-diacetoxystyryl sulfones and sulfoxides can significantly inhibit kinds of neuron cell injury induced by toxicities, including 6-OHDA, NO, and H2O2. More important, they show higher antineuroinflammatory properties and similar antioxidative properties to corresponding un-acetylated compounds. Thus, we suggest that (E)-3,4-diacetoxystyryl sulfones and sulfoxides may have potential for the treatment of neurodegenerative disorders, especially Parkinson's disease.

Keywords: (E)-3; 4-diacetoxystyryl sulfones and sulfoxides; Acetylated derivatives; neuroprotective agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemical synthesis
  • Antioxidants / chemistry
  • Antioxidants / pharmacology*
  • Cell Line
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Humans
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / pharmacology
  • Molecular Structure
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / pathology
  • Neuroprotective Agents / chemical synthesis
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacology*
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / biosynthesis
  • PC12 Cells
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / pathology*
  • Rats
  • Safrole / analogs & derivatives*
  • Safrole / chemical synthesis
  • Safrole / chemistry
  • Safrole / pharmacology
  • Structure-Activity Relationship
  • Styrenes / chemical synthesis
  • Styrenes / chemistry
  • Styrenes / pharmacology*
  • Sulfones / chemical synthesis
  • Sulfones / chemistry
  • Sulfones / pharmacology*

Substances

  • (E)-3,4-diacetoxystyryl sulfone
  • Antioxidants
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Styrenes
  • Sulfones
  • Nitric Oxide
  • Safrole
  • sulfoxide